| OALBX0104 | Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| EPC0430 | Sustained continuity of treatment for key populations in security challenged Zamfara state of Northern Nigeria | E-poster | Population-specific interventions for HIV prevention |
| EPB0234 | Sustained viral load suppression among people living with HIV on Dolutegravir-based regimen in Southern Nigeria | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPE0821 | Sustaining HIV service delivery among key populations amidst donor transition: implications for the 90-90-90 country targets | E-poster | Implementation science and scale up of treatment |
| EPE0879 | Sustaining key population-led HIV services as international donor funding declines: fragile success in domestic financing and social enterprise development in Thailand | E-poster | Global and national financing, economic evaluation and sustainability |
| EPD0545 | Sustaining resilience against HIV through community collective capacity: analysis of heterosexual Black men in Ontario, Canada | E-poster | Social and behavioural aspects and approaches to HIV |
| LBEPX59 | Swiping right on PrEP: a qualitative study of MSM preferences for PrEP public health messaging on dating apps | E-poster | Implementation science and scale up of prevention |
| EPB0218 | Switching to dolutegravir/lamivudine (DTG/3TC) is non-inferior to continuing tenofovir alafenamide (TAF)-based regimens at Week 196: TANGO subgroup analyses | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPA0075 | Synergistic effects of romidepsin with PI3K inhibitors in reducing the pool of HIV latently infected cells ex vivo | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPE0872 | Systematic review of person-centred care interventions for persons living with HIV in low and middle-income countries | E-poster | Implementation science and scale up of treatment |